Inventionmed (WAR:INM) Other Current Liabilities: zł14.41 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:INM Inventionmed SA WAR:INM
19 GF Score
Price zł0.10
! 7 Warning Signs
View Full Analysis

What is Inventionmed Other Current Liabilities?

Inventionmed WAR:INM +1.47% 19 Other Current Liabilities is zł14.41 Mil as of Mar. 2026. GuruFocus rates WAR:INM with a GF Score™ of 19/100. The stock has 7 warning signs investors should review.

Inventionmed's other current liabilities for the quarter that ended in Mar. 2026 was zł14.41 Mil.

Inventionmed's quarterly other current liabilities declined from Sep. 2025 (zł14.38 Mil) to Dec. 2025 (zł0.49 Mil) but then increased from Dec. 2025 (zł0.49 Mil) to Mar. 2026 (zł14.41 Mil).

Inventionmed's annual other current liabilities declined from Dec. 2023 (zł0.52 Mil) to Dec. 2024 (zł0.50 Mil) and declined from Dec. 2024 (zł0.50 Mil) to Dec. 2025 (zł0.49 Mil).

Inventionmed Other Current Liabilities Related Terms

Inventionmed Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Inventionmed's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventionmed Other Current Liabilities Chart

Inventionmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.77 10.31 0.52 0.50 0.49

Inventionmed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.68 14.69 14.38 0.49 14.41
WAR:INM
19GF Score
Inventionmed SA WAR:INM
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inventionmed Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of zł14.41 Mil mean?
Inventionmed (WAR:INM) has a Other Current Liabilities of zł14.41 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Inventionmed.
Is Inventionmed's Other Current Liabilities too high?
Inventionmed's current Other Current Liabilities is zł14.41 Mil. Overall, Inventionmed has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Inventionmed's Other Current Liabilities compare to ABT and SYK?
Inventionmed's Other Current Liabilities of zł14.41 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Inventionmed. Inventionmed's current Other Current Liabilities is zł14.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inventionmed stock overvalued right now?
Inventionmed (WAR:INM) has a current Other Current Liabilities of zł14.41 Mil. The current Other Current Liabilities is zł14.41 Mil. Inventionmed's overall GF Score™ is 19/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Inventionmed (WAR:INM), the current Other Current Liabilities is zł14.41 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inventionmed Business Description

Address Jana Zamoyskiego 2B Street, Bydgoszcz, POL, 85-063
Inventionmed SA focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology. The company's project consists of TutorDerm, Double immersion, Virtual Syringe, and others.
19GF Score

Get the complete analysis for WAR:INM

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.10
Price